These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5374477)

  • 1. Cerebrotendinous xanthomatosis: a generalized disorder of cholestanol metabolism.
    Philippart M; van Bogaert L
    Trans Am Neurol Assoc; 1969; 94():322-4. PubMed ID: 5374477
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism.
    Salen G
    Ann Intern Med; 1971 Dec; 75(6):843-51. PubMed ID: 5134895
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma esterification of cholestanol, normally and in cerebrotendinous xanthomatosis.
    Skrede S; Stokke KT
    Scand J Clin Lab Invest; 1974 Apr; 33(2):97-100. PubMed ID: 4853665
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholestanol storage in the nervous system of two patients with cerebrotendinous xanthomatosis.
    Menkes JH; Philippart M
    Trans Am Neurol Assoc; 1968; 93():66-9. PubMed ID: 5711054
    [No Abstract]   [Full Text] [Related]  

  • 5. Subcellular distribution of cerebral cholestanol in cerebrotendinous xanthomatosis.
    Stahl WL; Sumi SM; Swanson PD
    J Neurochem; 1971 Mar; 18(3):403-13. PubMed ID: 5559251
    [No Abstract]   [Full Text] [Related]  

  • 6. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Tint GS
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of 5 -cholestan-3 -ol in cerebrotendinous xanthomatosis.
    Salen G; Polito A
    J Clin Invest; 1972 Jan; 51(1):134-40. PubMed ID: 4550120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrotendinous xanthomatosis: in vivo labeling of cerebral sterols and sterol esters.
    Gardner-Medwin D; Kishimoto Y; Derby BM; Moser HW
    Trans Am Neurol Assoc; 1971; 96():241-4. PubMed ID: 5159092
    [No Abstract]   [Full Text] [Related]  

  • 9. Type IIa hyperlipoproteinemia masquerading as cerebrotendinous xanthomatosis.
    Ijichi S; Ijichi N; Niina K; Kuriyama M; Izumo S; Nakamura F; Osame M
    J Neurol Sci; 1989 Dec; 94(1-3):101-5. PubMed ID: 2614461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
    Pedley TA; Emerson RG; Warner CL; Rowland LP; Salen G
    Ann Neurol; 1985 Oct; 18(4):517-8. PubMed ID: 4073846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrotendinous xanthomatosis with cholestanolaemia--involvement of five individuals in a Malay family.
    Othman NH; Rahman SA
    Med J Malaysia; 1990 Dec; 45(4):275-80. PubMed ID: 2152046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism of biosynthesis of cholestanol from 7 alpha-hydroxycholesterol.
    Buchmann MS; Björkhem I; Lund AM; Skrede S
    Scand J Clin Lab Invest Suppl; 1986; 184():41-6. PubMed ID: 3109015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrotendinous xanthomatosis. The storage of cholestanol within the nervous system.
    Menkes JH; Schimschock JR; Swanson PD
    Arch Neurol; 1968 Jul; 19(1):47-53. PubMed ID: 5676919
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cerebrotendinous xanthomatosis and phytosterolemia].
    Nakamura T; Matsuzawa Y
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):794-7. PubMed ID: 3152095
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cerebrotendinous xanthomatosis].
    Kito S
    Nihon Rinsho; 1978 May; Suppl():1698-9. PubMed ID: 691484
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of cerebrotendinous xanthomatosis. II: The sterol content of a cataractous lens.
    McKenna P; Morgan SJ; Bosanquet RC; Laker MF
    Br J Ophthalmol; 1990 Oct; 74(10):629-30. PubMed ID: 2285688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations.
    Moghadasian MH; Salen G; Frohlich JJ; Scudamore CH
    Arch Neurol; 2002 Apr; 59(4):527-9. PubMed ID: 11939886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrotendinous xanthomatosis.
    Kearns WP; Wood WS
    Arch Ophthalmol; 1976 Jan; 94(1):148-50. PubMed ID: 1247403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Congenital disorders of the bile acid metabolism (3 beta-hydroxy-delta 5-steroid dehydrogenase/isomerase deficiency, delta 4-3-oxosteroid 5 beta-reductase deficiency, cerebrotendinous xanthomatosis, and peroxisomal disorders].
    Kondo KH; Maeda Y; Setoguchi T
    Ryoikibetsu Shokogun Shirizu; 1995; (8):362-6. PubMed ID: 8581653
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebrotendinous cholestanolosis in relation to other cerebral xanthomatoses.
    de Jong JG; van Gent CM; Delleman JW
    Clin Neurol Neurosurg; 1977; 79(4):253-72. PubMed ID: 200389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.